Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Clinical results on intra-arterial adjuvant chemotherapy for prevention
of liver metastasis following curative resection of pancreatic cancer
In this study, the investigator try to select 80 patients who received radical surgery for pancreatic cancer, whose circulating tumor cells(CTCs) count then performed on intraoperative portal venous blood to predict postoperative liver metastasis and were divided into two groups. for those who have high CTCs count may have more chance for the occurrence of postoperative liver metastasis was applied hepatic arterial perfusion chemotherapy with minimal dynamic randomization. The aim is to evaluate the feasibility of hepatic arterial infusion chemotherapy for the prevention of postoperative liver metastasis and improvement of prognosis of pancreatic cancer, so as to further improve postoperative management of pancreatic cancer
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intrahepatic Arterial Infusion chemotherapy | Experimental | chemotherapy through intrahepatic arterial Infusion is one of the most widely used liver tumor treatments. |
|
| control | No Intervention | chemotherapy through Peripheral venous is one of the regularly used method. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Intrahepatic Arterial Infusion | Device | Intrahepatic Arterial Infusion chemotherapy is one of the most widely used liver tumor treatments. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Death | Overall survival time after operation | up to 12 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| dianrong xiu, doctor | Peking University Third Hospital | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of General Surgery,Peking University Third Hospital | Beijing | Beijing Municipality | 100191 | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Pancreatic cancer patients who received hepatic arterial perfusion chemotherapy after operation
Not provided
Not provided
Pancreatic cancer patients who received chemotherapy through peripheral vein after operation